Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model??
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 19483747.
- Also identified by DOI 10.1038/ki.2009.82.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The cytochrome P450-derived 20-hydroxyeicosatetraenoic acid (20-HETE) has known function that plays opposite roles in blood pressure: prohypertensive and antihypertensive. Liu et al. report that the CYP4F2 transgene, driven under an exogenous promoter, increases 20-HETE production and is associated with increased blood pressure in vivo. This study provides evidence for the first time that overexpression of P450 4F2 enzyme results in higher production of 20-HETE, which promotes hypertension. The significance of this transgenic mouse model is further discussed.
Medical subject headings
- Cytochrome P-450 Enzyme System
- Hypertension